SZV-1287 is a new 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime SSAO inhibitor.
Structure of oxime derivatives described as TRPA1 antagonists is similar to SZV1287.
SZV-1287 exerts inhibition on both TRPA1 and TRPV1 activation in TRG neurons.
SZV-1287 inhibits the TRPA1, but not the TRPV1 activation on sensory nerve endings.
SZV-1287 inhibits the TRPA1 and TRPV1 activation in receptor-expressing cell lines.